Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kastelein, JJP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 153 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. van Geel, PP; Pinto, YM; Zwinderman, AH; Henning, RH; van Boven, A; Jukema, JW; Bruschke, AVG; Kastelein, JJP; van Gilst, WH
      Increased risk for ischaemic events is related to combined RAS polymorphism

      HEART
    2. van Dam, M; Stalenhoef, AFH; Wittekoek, J; Trip, MD; Prins, MH; Kastelein, JJP
      Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia - A comparison with gemfibrozil

      CLINICAL DRUG INVESTIGATION
    3. Sijbrands, EJG; Westendorp, RGJ; Defesche, JC; de Meier, PHEM; Smelt, AHM; Kastelein, JJP
      Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study

      BRITISH MEDICAL JOURNAL
    4. Smilde, TJ; van Wissen, S; Wollersheim, H; Kastelein, JJP; Stalenhoef, AFH
      Genetic and metabolic factors predicting risk of cardiovascular disease infamilial hypercholesterolemia

      NETHERLANDS JOURNAL OF MEDICINE
    5. Agema, WRP; Jukema, JW; Pimstone, SN; Kastelein, JJP
      Genetic aspects of restenosis after percutaneous coronary interventions - Towards more tailored therapy

      EUROPEAN HEART JOURNAL
    6. Doevendans, PA; Jukema, W; Spiering, W; Defesche, JC; Kastelein, JJP
      Molecular genetics and gene expression in atherosclerosis

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    7. van Dam, MJ; Penn, HJAM; den Hartog, FR; Kragten, HA; Trip, MD; Buirma, RJA; Kastelein, JJP
      A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: A randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease

      CLINICAL THERAPEUTICS
    8. ten Asbroek, AHA; Marang-van de Mheen, PJ; Defesche, JC; Kastelein, JJP; Gunning-Schepers, LJ
      Results from a family and DNA based active identification programme for familial hypercholesterolaemia

      JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
    9. Smilde, TJ; van Wissen, S; Kastelein, JJP; Stalenhoef, AFH
      Measurement of atherosclerosis progression - Reply

      LANCET
    10. Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EGJ; Kastelein, JJP
      Familial hypercholesterolaemia - Reply

      LANCET
    11. Smilde, TJ; van Wissen, S; Wollersheim, H; Trip, MD; Kastelein, JJP; Stalenhoef, AFH
      Effect of aggressive versus conventional lipid lowering on atherosclerosisprogression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

      LANCET
    12. Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EJG; Scheerder, RLJM; Kastelein, JJP
      Review of first 5 years of screening for familial hypercholesterolaemia inthe Netherlands

      LANCET
    13. Boer, JMA; Feskens, EJM; Kuivenhoven, JA; Schouten, EG; Havekes, LM; Kastelein, JJP; Seidell, JC; Kromhout, D
      Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle

      ATHEROSCLEROSIS
    14. Leus, FR; Zwart, M; Kastelein, JJP; Voorbij, HAM
      PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

      ATHEROSCLEROSIS
    15. Clee, SM; Loubser, O; Collins, J; Kastelein, JJP; Hayden, MR
      The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease

      CLINICAL GENETICS
    16. Smilde, TJ; Trip, MD; Wollersheim, H; van Wissen, S; Kastelein, JJP; Stalenhoef, AFH
      Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia - The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study

      CLINICAL DRUG INVESTIGATION
    17. van Dam, M; Basart, DCG; Janus, C; Zwertbroek, R; Spierenburg, HAM; Werner, HA; Bredero, AC; Lansberg, PJ; Jonker, CJ; Trip, MD; Prins, MH; Kastelein, JJP
      Additional efficacy of milligram-equivalent doses of atorvastatin over simvastatin

      CLINICAL DRUG INVESTIGATION
    18. Lu, GQ; Excoffon, KJDA; Wilson, JE; McManus, BM; Rogers, QR; Miao, L; Kastelein, JJP; Lewis, MES; Hayden, MR
      Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer

      HUMAN GENE THERAPY
    19. Kastelein, JJP
      Screening for familial hypercholesterolaemia - Effective, safe treatments and DNA testing make screening attractive

      BRITISH MEDICAL JOURNAL
    20. Hayden, MR; Clee, SM; Brooks-Wilson, A; Genest, J; Attie, A; Kastelein, JJP
      Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency

      CURRENT OPINION IN LIPIDOLOGY
    21. Davidson, MH; Stein, EA; Hunninghake, DB; Ose, L; Dujovne, CA; Insull, W; Bertolami, M; Weiss, SR; Kastelein, JJP; Scott, RS; Campodonico, S; Escobar, ID; Schrott, HG; Bays, H; Stepanavage, ME; Wu, M; Tate, AC; Melino, MR; Kush, D; Mercuri, M; Mitchel, YB
      Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    22. Ose, L; Davidson, MH; Stein, EA; Kastelein, JJP; Scott, RS; Hunninghake, DB; Campodonico, S; Insull, W; Escobar, ID; Schrott, HG; Stepanavage, ME; Wu, M; Tate, AC; Melino, MR; Mercuri, M; Mitchel, YB
      Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia

      CLINICAL CARDIOLOGY
    23. Clee, SM; Bissada, N; Miao, FD; Miao, L; Marais, AD; Henderson, HE; Steures, P; McManus, J; McManus, B; LeBoeuf, RC; Kastelein, JJP; Hayden, MR
      Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis

      JOURNAL OF LIPID RESEARCH
    24. Clee, SM; Kastelein, JJP; van Dam, M; Marcil, M; Roomp, K; Zwarts, KY; Collins, JA; Roelants, R; Tamasawa, N; Stulc, T; Suda, T; Ceska, R; Boucher, B; Rondeau, C; DeSouich, C; Brooks-Wilson, A; Molhuizen, HOF; Frohlich, J; Genest, J; Hayden, MR
      Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes

      JOURNAL OF CLINICAL INVESTIGATION
    25. Stalenhoef, AFH; de Graaf, J; Wittekoek, ME; Bredie, SJH; Demacker, PNM; Kastelein, JJP
      The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia

      ATHEROSCLEROSIS
    26. Hoffer, MJV; Snieder, H; Bredie, SJH; Demacker, PNM; Kastelein, JJP; Frants, RR; Stalenhoef, AFH
      The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia

      ATHEROSCLEROSIS
    27. Leus, FR; Wittekoek, ME; Prins, J; Kastelein, JJP; Voorbij, HAM
      Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia

      ATHEROSCLEROSIS
    28. Sijbrands, EJG; Westendorp, RGJ; Lombardi, MP; Havekes, LM; Frants, RR; Kastelein, JJP; Smelt, AHM
      Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia

      ATHEROSCLEROSIS
    29. Khoo, KL; van Acker, P; Defesche, JC; Tan, H; van de Kerkhof, L; Heijnen-van Eijk, SJ; Kastelein, JJP; Deslypere, JP
      Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia

      CLINICAL GENETICS
    30. Lombardi, MP; Redeker, EJW; Defesche, JC; Kamerling, SWA; Trip, MD; Mannens, MMAM; Havekes, LM; Kastelein, JJP
      Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the Netherlands

      CLINICAL GENETICS
    31. Kastelein, JJP; Jukema, JW; Zwinderman, AH; Clee, S; van Boven, AJ; Jansen, H; Rabelink, TJ; Peters, RJG; Lie, KI; Liu, G; Bruschke, AVG; Hayden, MR
      Lipoprotein lipase activity is associated with severity of angina pectoris

      CIRCULATION
    32. Verhaar, MC; Wever, RMF; Kastelein, JJP; van Loon, D; Milstien, S; Koomans, H; Rabelink, T
      Folic acid in endothelial function in familial hypercholesterolemia - Response

      CIRCULATION
    33. Heikens, J; Ubbink, MC; van der Pal, HPJ; Bakker, PJM; Fliers, E; Smilde, TJ; Kastelein, JJP; Trip, MD
      Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease

      CANCER
    34. Kastelein, JJP; Isaacsohn, JL; Ose, L; Hunninghake, DB; Frohlich, J; Davidson, MH; Habib, R; Dujovne, CA; Crouse, JR; Liu, MZ; Melino, MR; O'Grady, L; Mercuri, M; Mitchel, YB
      Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

      AMERICAN JOURNAL OF CARDIOLOGY
    35. Wittekoek, ME; Moll, E; Pimstone, SN; Trip, MD; Lansberg, PJ; Defesche, JC; van Doormaal, JJ; Hayden, MR; Kastelein, JJP
      A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    36. Minnema, MC; Wittekoek, ME; Schoonenboom, N; Kastelein, JJP; Hack, CE; ten Cate, H
      Activation of the contact system of coagulation does not contribute to thehemostatic imbalance in hypertriglyceridemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    37. Brooks-Wilson, A; Marcil, M; Clee, SM; Zhang, LH; Roomp, K; van Dam, M; Yu, L; Brewer, C; Collins, JA; Molhuizen, HOF; Loubser, O; Ouelette, BFF; Fichter, K; Ashbourne-Excoffon, KJD; Sensen, CW; Scherer, S; Mott, S; Denis, M; Martindale, D; Frohlich, J; Morgan, K; Koop, B; Pimstone, S; Kastelein, JJP; Genest, J; Hayden, MR
      Mutations in ABC1 in Tangier disease and familial high-density lipoproteindeficiency

      NATURE GENETICS
    38. Marcil, M; Brooks-Wilson, A; Clee, SM; Roomp, K; Zhang, LH; Yu, L; Collins, JA; van Dam, M; Molhuizen, HOF; Loubster, O; Ouellette, BFF; Sensen, CW; Fichter, K; Mott, S; Denis, M; Boucher, B; Pimstone, S; Genest, J; Kastelein, JJP; Hayden, MR
      Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux

      LANCET
    39. Henderson, HE; Kastelein, JJP; Zwinderman, AH; Gagne, E; Jukema, JW; Reymer, PWA; Groenemeyer, BE; Lie, KI; Bruschke, AVG; Hayden, MR; Jansen, H
      Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins

      JOURNAL OF LIPID RESEARCH
    40. Wittekoek, ME; de Groot, E; Prins, MH; Trip, MD; Buller, HR; Kastelein, JJP
      Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease

      ATHEROSCLEROSIS
    41. Kastelein, JJP
      Bringing about best practice in atherosclerosis - Proceedings of a Satellite Symposium held at the 70th Congress of the European Atherosclerosis Society, Geneva, Switzerland, 6 September 1998

      ATHEROSCLEROSIS
    42. Kastelein, JJP
      The future of best practice

      ATHEROSCLEROSIS
    43. Kastelein, JJP; Ordovas, JM; Wittekoek, ME; Pimstone, SN; Wilson, PWF; Gagne, SE; Larson, MG; Schaefer, EJ; Boer, JMA; Gerdes, C; Hayden, MR
      Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women

      CLINICAL GENETICS
    44. Boer, JMA; Kuivenhoven, JA; Feskens, EJM; Schouten, EG; Havekes, LM; Seidell, JC; Kastelein, JJP; Kromhout, D
      Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins

      CLINICAL GENETICS
    45. Gagne, SE; Larson, MG; Pimstone, SN; Schaefer, EJ; Kastelein, JJP; Wilson, PWF; Ordovas, JM; Hayden, MR
      A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

      CLINICAL GENETICS
    46. Verhaar, MC; Wever, RMF; Kastelein, JJP; van Loon, D; Milstien, S; Koomans, HA; Rabelink, TJ
      Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia - A randomized placebo-controlled trial

      CIRCULATION
    47. Verhaar, MC; Honing, MLH; van Dam, T; Zwart, M; Koomans, HA; Kastelein, JJP; Rabelink, TJ
      Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids

      CARDIOVASCULAR RESEARCH
    48. Franco, RF; Trip, MD; ten Cate, H; van den Ende, A; Prins, MH; Kastelein, JJP; Reitsma, PH
      The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease

      BRITISH JOURNAL OF HAEMATOLOGY
    49. Hallman, DM; Groenemeijer, BE; Jukema, JW; Boerwinkle, E; Kastelein, JJP
      Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci

      ANNALS OF HUMAN GENETICS
    50. de Maat, MPM; Jukema, JW; Ye, S; Zwinderman, AH; Moghaddam, PH; Beekman, M; Kastelein, JJP; van Boven, AJ; Bruschke, AVG; Humphries, SE; Kluft, C; Henney, AM
      Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

      AMERICAN JOURNAL OF CARDIOLOGY
    51. DEMAAT MPM; KASTELEIN JJP; JUKEMA JW; ZWINDERMAN AH; JANSEN H; GROENEMEIER B; BRUSCHKE AVG; KLUFT C
      -455G A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE IS ASSOCIATED WITH THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC MEN - PROPOSED ROLE FOR AN ACUTE-PHASE REACTION PATTERN OF FIBRINOGEN/

      Arteriosclerosis, thrombosis, and vascular biology
    52. OSE L; KASTELEIN JJP; SCOTT R; STEIN EA; CAMPODONICO S; ESCOBAR ID; TATE AC; CORSETTI L; SHAHANE A; MITCHEL YB; MERCURI M
      EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    53. UMANSECKENHAUSEN MAW; DEFESCHE JC; KASTELEIN JJP
      FAMILIAR HYPERCHOLESTEROLEMIA - THE LIMITED PREDICTIVE VALUE OF PLASMA LDL-CHOLESTEROL

      Journal of the American College of Cardiology
    54. UMANSECKENHAUSEN MAW; DEFESCHE JC; CLINE F; KASTELEIN JJP
      A NATIONAL SCREENING-PROGRAM FOR THE IDENTIFICATION OF PERSONS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS

      Journal of the American College of Cardiology
    55. HENDERSON HE; BIJVOET SM; MANNENS MAMM; BRUIN T; ERKELENS DW; HAYDEN MR; KASTELEIN JJP
      ILE(225)THR LOOP MUTATION IN THE LIPOPROTEIN-LIPASE (LPL) GENE IS A DE-NOVO EVENT

      American journal of medical genetics
    56. DEFESCHE JC; KASTELEIN JJP
      MOLECULAR EPIDEMIOLOGY OF FAMILIAL HYPERCHOLESTEROLEMIA

      Lancet
    57. PRINS J; VANDERHOEK YY; BIESHEUVEL TH; LEUS FR; VANRIJN HJM; KASTELEIN JJP
      THE FUNCTIONAL AND CLINICAL-SIGNIFICANCE OF THE MET-]THR SUBSTITUTIONIN KRINGLE-IV TYPE-10 OF APOLIPOPROTEIN(A)

      Thrombosis research
    58. KUIVENHOVEN JA; KASTELEIN JJP
      POLYMORPHISM OF THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE - REPLY

      The New England journal of medicine
    59. KUIVENHOVEN JA; JUKEMA JW; ZWINDERMAN AH; DEKNIJFF P; MCPHERSON R; BRUSCHKE VG; LIE KI; KASTELEIN JJP
      THE ROLE OF A COMMON VARIANT OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE IN THE PROGRESSION OF CORONARY ATHEROSCLEROSIS

      The New England journal of medicine
    60. VONECKARDSTEIN A; CHIRAZI A; SCHULERLUTTMANN S; WALTER M; KASTELEIN JJP; GEISEL J; REAL JT; MICCOLI R; NOSEDA G; HOBBEL G; ASSMANN G
      PLASMA AND FIBROBLASTS OF TANGIER-DISEASE PATIENTS ARE DISTURBED IN TRANSFERRING PHOSPHOLIPIDS ONTO APOLIPOPROTEIN-A-I

      Journal of lipid research
    61. DIEKMANN T; DEMACKER PNM; KASTELEIN JJP; STALENHOEF AFH; WIERSINGA WM
      INCREASED OXIDIZABILITY OF LOW-DENSITY LIPOPROTEINS IN HYPOTHYROIDISM

      The Journal of clinical endocrinology and metabolism
    62. VONECKARDSTEIN A; HUANG YD; KASTELEIN JJP; GEISEL J; REAL JT; KUIVENHOVEN JA; MICCOLI R; NOSEDA G; ASSMANN G
      LIPID-FREE APOLIPOPROTEIN (APO) A-I IS CONVERTED INTO ALPHA-MIGRATINGHIGH-DENSITY-LIPOPROTEINS BY LIPOPROTEIN-DEPLETED PLASMA OF NORMOLIPIDEMIC DONORS AND APO A-I-DEFICIENT PATIENTS BUT NOT OF TANGIER-DISEASEPATIENTS

      Atherosclerosis
    63. HOFFER MJV; BREDIE SJH; SNIEDER H; REYMER PWA; DEMACKER PNM; HAVEKES LM; BOOMSMA DI; STALENHOEF AFH; FRANTS RR; KASTELEIN JJP
      GENDER-RELATED ASSOCIATION BETWEEN THE -93T-]G D9N HAPLOTYPE OF THE LIPOPROTEIN-LIPASE GENE AND ELEVATED LIPID-LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA/

      Atherosclerosis
    64. STALENHOEF AFH; BREDIE SJH; KASTELEIN JJP; FRANTS RR; HOFFER MJV
      LIPASE GENE-MUTATIONS AND FAMILIAL COMBINED HYPERLIPIDEMIA PHENOTYPES

      Atherosclerosis (Amsterdam)
    65. Verhoeff, BJ; Trip, MD; Prins, MH; Kastelein, JJP; Reitsma, PH
      The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis

      ATHEROSCLEROSIS
    66. KASTELEIN JJP; GROENEMEYER BD; HALLMAN DM; HENDERSON H; REYMER PWA; GAGNE SE; JANSEN H; SEIDELL JC; KROMHOUT D; JUKEMA JW; BRUSCHKE AVG; BOERWINKLE E; HAYDEN MR
      THE ASN9 VARIANT OF LIPOPROTEIN-LIPASE IS ASSOCIATED WITH THE -93G PROMOTER MUTATION AND AN INCREASED RISK OF CORONARY-ARTERY DISEASE

      Clinical genetics
    67. VERHAAR MC; HONING MLH; VANDAM T; ZWART M; KOOMANS HA; KASTELEIN JJP; RABELINK TJ
      NIFEDIPINE IMPROVES NO MEDIATED VASODILATION IN HYPERCHOLESTEROLEMIA,INDEPENDENT OF AN EFFECT ON BLOOD-PRESSURE OR PLASMA-LIPIDS

      Circulation
    68. KASTELEIN JJP; WITTEKOEK ME; LOUBSER O; CLEE SM; COLLINS J; MOLL E; PIMSTONE SN; HAYDEN MR
      COMMON VARIANTS OF LIPOPROTEIN-LIPASE (LPL) STRONGLY INFLUENCE LEVELSOF LIPIDS AND LIPOPROTEINS AND CORONARY-ARTERY DISEASE (CAD) IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)

      Circulation
    69. KASTELEIN JJP; JUKEMA JW; VANBOVEN AJ; JANSEN H; ZWINDERMAN AH; RABELINK TJ; PETERS RJG; LIE KI; BRUSCHKE AVG; HAYDEN MR
      LIPOPROTEIN-LIPASE (LPL) ACTIVITY IS DECREASED IN CAD PATIENTS AND INVERSELY CORRELATED WITH SEVERITY OF ANGINA-PECTORIS AND SILENT-MYOCARDIAL-ISCHEMIA

      Circulation
    70. WITTEKOEK ME; PIMSTONE SN; REYMER PWA; FEUTH L; BOTMA GJ; DEFESCHE JC; PRINS M; HAYDEN MR; KASTELEIN JJP
      A COMMON MUTATION IN THE LIPOPROTEIN-LIPASE GENE (N291S) ALTERS THE LIPOPROTEIN PHENOTYPE AND RISK FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

      Circulation
    71. VERHAAR MC; WEVER RMF; KASTELEIN JJP; VANDAM T; KOOMANS HA; RABELINK TJ
      5-METHYLTETRAHYDROFOLATE, THE ACTIVE FORM OF FOLIC-ACID, RESTORES ENDOTHELIAL FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA

      Circulation
    72. FRANCO RF; ZAGO MA; TRIP MD; TENCATE H; VANDENENDE A; PRINS MH; KASTELEIN JJP; REITSMA PH
      PREVALENCE OF HEREDITARY HEMOCHROMATOSIS IN PREMATURE ATHEROSCLEROTICVASCULAR-DISEASE

      British Journal of Haematology
    73. FRANCO RF; TRIP MD; TENCATE H; VANDENENDE A; PRINS MH; KASTELEIN JJP; REITSMA PH
      FACTOR-11 20210-G-]A POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK FOR ARTERIAL THROMBOTIC DISEASE AND AUGMENTED THROMBIN GENERATION

      British Journal of Haematology
    74. FRANCO RF; TRIP MD; TENCATE H; PRINS MH; KASTELEIN JJP; ZAGO MA; REITSMA PH
      PREVALENCE OF HLA-H MUTATIONS IN PATIENTS WITH PREMATURE ARTERIAL-DISEASE

      British Journal of Haematology
    75. PIMSTONE SN; DEFESCHE JC; CLEE SM; BAKKER HD; HAYDEN MR; KASTELEIN JJP
      DIFFERENCES IN THE PHENOTYPE BETWEEN CHILDREN WITH FAMILIAL DEFECTIVEAPOLIPOPROTEIN B-100 AND FAMILIAL HYPERCHOLESTEROLEMIA

      Arteriosclerosis, thrombosis, and vascular biology
    76. HANSEN PS; DEFESCHE JC; KASTELEIN JJP; GERDES LU; FRAZA L; GERDES C; TATO F; JENSEN HK; JENSEN LG; KLAUSEN IC; FAERGEMAN O; SCHUSTER H
      PHENOTYPIC VARIATION IN PATIENTS HETEROZYGOUS FOR FAMILIAL DEFECTIVE APOLIPOPROTEIN-B (FDB) IN 3 EUROPEAN COUNTRIES

      Arteriosclerosis, thrombosis, and vascular biology
    77. KUIVENHOVEN JA; DEKNIJFF P; BOER JMA; SMALHEER HA; BOTMA GJ; SEIDELL JC; KASTELEIN JJP; PRITCHARD PH
      HETEROGENEITY AT THE CETP GENE LOCUS - INFLUENCE ON PLASMA CETP CONCENTRATIONS AND HDL CHOLESTEROL LEVELS

      Arteriosclerosis, thrombosis, and vascular biology
    78. KUIVENHOVEN JA; GROENEMEYER BE; BOER JMA; REYMER PWA; BERGHUIS R; BRUIN T; JANSEN H; SEIDELL JC; KASTELEIN JJP
      SER(447STOP) MUTATION IN LIPOPROTEIN-LIPASE IS ASSOCIATED WITH ELEVATED HDL CHOLESTEROL LEVELS IN NORMOLIPIDEMIC MALES

      Arteriosclerosis, thrombosis, and vascular biology
    79. EHRENBORG E; CLEE SM; PIMSTONE SN; REYMER PWA; BENLIAN P; HOOGENDIJK CF; DAVIS HJ; BISSADA N; MIAO L; GAGNE SE; GREENBERG LJ; HENRY R; HENDERSON H; ORDOVAS JM; SCHAEFER EJ; KASTELEIN JJP; KOTZE MJ; HAYDEN MR
      ETHNIC VARIATION AND IN-VIVO EFFECTS OF THE -93T-]G PROMOTER VARIANT IN THE LIPOPROTEIN-LIPASE GENE

      Arteriosclerosis, thrombosis, and vascular biology
    80. JANSEN H; VERHOEVEN AJM; WEEKS L; KASTELEIN JJP; HALLEY DJJ; VANDENOUWELAND A; JUKEMA JW; SEIDELL JC; BIRKENHAGER JC
      COMMON C-TO-T SUBSTITUTION AT POSITION--480 OF THE HEPATIC LIPASE PROMOTER ASSOCIATED WITH A LOWERED LIPASE ACTIVITY IN CORONARY-ARTERY DISEASE PATIENTS

      Arteriosclerosis, thrombosis, and vascular biology
    81. KOCKX M; DEMAAT MPM; KNIPSCHEER HC; KASTELEIN JJP; KLUFT C; PRINCEN HMG; KOOISTRA T
      EFFECTS OF GEMFIBROZIL AND CIPROFIBRATE ON PLASMA-LEVELS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND FIBRINOGEN IN HYPERLIPIDEMIC PATIENTS

      Thrombosis and haemostasis
    82. PRINS J; LEUS FR; VANDERHOEK YY; KASTELEIN JJP; BOUMA BN; VANRIJN HJM
      THE IDENTIFICATION AND SIGNIFICANCE OF A THR-]PRO POLYMORPHISM IN KRINGLE-IV TYPE-8 OF APOLIPOPROTEIN(A)

      Thrombosis and haemostasis
    83. DEMAAT MPM; KNIPSCHEER HC; KASTELEIN JJP; KLUFT C
      MODULATION OF PLASMA-FIBRINOGEN LEVELS BY CIPROFIBRATE AND GEMFIBROZIL IN PRIMARY HYPERLIPIDEMIA

      Thrombosis and haemostasis
    84. FRANCO RF; TRIP MD; TENCATE H; PRINS MH; KASTELEIN JJP; REITSMA PH
      THE PREVALENCE OF THE 20210-G-GREATER-THAN-A MUTATION IN THE 3'-UNTRANSLATED REGION OF THE PROTHROMBIN GENE IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE

      Thrombosis and haemostasis
    85. KNIPSCHEER HC; KINDT I; VANDENENDE A; NURMOHAMED MT; SMALBRAAK H; MULDER WJ; KASTELEIN JJP
      MAGNESIUM PYRIDOXAL-5'-PHOSPHATE GLUTAMATE, A VITAMIN-B-6 DERIVATIVE,DOES NOT AFFECT LIPOPROTEIN LEVELS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

      European Journal of Clinical Pharmacology
    86. VANDERHOEK YY; WANDERS RJA; VANDENENDE AE; KRAFT HG; GABEL BR; KASTELEIN JJP; KOSCHINSKY ML
      LIPOPROTEIN[A] IS NOT PRESENT IN THE PLASMA OF PATIENTS WITH SOME PEROXISOMAL DISORDERS

      Journal of lipid research
    87. VANDERHOEK YY; LINGENHEL A; KRAFT HG; DEFESCHE JC; KASTELEIN JJP; UTERMANN G
      SIB-PAIR ANALYSIS DETECTS ELEVATED LP(A) LEVELS AND LARGE VARIATION OF LP(A) CONCENTRATION IN SUBJECTS WITH FAMILIAR DEFECTIVE APO-B

      The Journal of clinical investigation
    88. LOOKENE A; GROOT NB; KASTELEIN JJP; OLIVECRONA G; BRUIN T
      MUTATION OF TRYPTOPHAN RESIDUES IN LIPOPROTEIN-LIPASE - EFFECTS ON STABILITY, IMMUNOREACTIVITY, AND CATALYTIC PROPERTIES

      The Journal of biological chemistry
    89. HAYDEN MR; GAGNE SE; LARSON MG; WITTEKOEK ME; PIMSTONE SN; SCHAEFER EJ; DEFESCHE JC; WILSON PWF; KASTELEIN JJP; ORDOVAS JM
      COMMON MUTATIONS IN THE LIPOPROTEIN-LIPASE GENE INFLUENCE PLASMA-LIPIDS AND PREVALENCE OF CORONARY HEART-DISEASE

      Atherosclerosis
    90. DEFESCHE JC; WITTEKOEK ME; KASTELEIN JJP
      FAMILIAL HYPERCHOLESTEROLEMIA - MOLECULAR-GENETICS AND CLINICAL EXPRESSION

      Atherosclerosis
    91. DEGROOT E; WIEGMAN A; GORT J; BOSVELD JE; KASTELEIN JJP
      DIGITAL AND ANALOG STORAGE AND ANALYSIS OF B-MODE ULTRASOUND IMAGES OF CAROTID ARTERIAL-WALLS IN CHILDREN

      Atherosclerosis
    92. DEFESCHE JC; LOMBARDI MP; KAMERLING SWA; HAVEKES LM; KASTELEIN JJP
      HETEROGENEITY OF LDL - RECEPTOR MUTATIONS IN DUTCH FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS

      Atherosclerosis
    93. LOMBARDI MP; DEFESCHE JC; KAMERLING SWA; REDEKER E; KASTELEIN JJP; HAVEKES LM
      NOVEL MUTATIONS IN THE LDL RECEPTOR GENE OF DUTCH FAMILIAR HYPERCHOLESTEROLEMIC PATIENTS

      Atherosclerosis
    94. REDEKER E; DEFESCHE JC; LOMBARDI P; KASTELEIN JJP; MANNENS M
      FREQUENCY AND GEOGRAPHICAL-DISTRIBUTION OF FAMILIAL HYPERCHOLESTEROLEMIA CAUSING MUTATIONS IN THE NETHERLANDS

      Atherosclerosis
    95. DEMAAT MPM; JUKEMA JW; YE S; ZWINDERMAN AH; BEEKMAN M; KASTELEIN JJP; BRUSCHKE AVG; HUMPHRIES SE; KLUFT C; HENNEY AM
      STROMELYSIN PROMOTER POLYMORPHISM IS ASSOCIATED WITH THE PROGRESSION OF CORONARY HEART-DISEASE

      Atherosclerosis
    96. WITTEKOEK ME; DEFESCHE JC; FEUTH L; BOTMA GJ; REYMER PWA; KASTELEIN JJP
      THE ASN201-]SER MUTATION IN THE LIPOPROTEIN-LIPASE GENE INCREASES THECARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

      Atherosclerosis
    97. DEFESCHE JC; LOMBARDI PR; REDEKER BJW; MANNENS MA; KASTELEIN JJP
      2 FOUNDER MUTATIONS CAUSING FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS

      Atherosclerosis
    98. LOMBARDI MP; DEFESCHE J; KAMERLING S; KASTELEIN JJP; HAVEKES LM
      2 NOVEL MUTATIONS IN THE GENE FOR THE LOW-DENSITY-LIPOPROTEIN RECEPTOR OF DUTCH PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

      Atherosclerosis
    99. DEFESCHE JC; KASTELEIN JJP
      IDENTIFICATION OF PATIENTS WITH INHERITED HYPERCHOLESTEROLEMIA - A NEW PARADIGM FOR THE TRACING OF DOMINANT GENETIC-DISORDERS

      Atherosclerosis
    100. LOMBARDI P; DEFESCHE JC; KAMERLING SWA; KASTELEIN JJP; HAVEKES LM
      A NOVEL MUTATION M-21V IN EXON-1 OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA

      Clinical genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 23:01:04